Top Markets
Coin of the day
TaiwanJ Pharmaceuticals Co., Ltd. TaiwanJ Pharmaceuticals Co., Ltd.

TaiwanJ Pharmaceuticals Co., Ltd.

6549
Peringkat dalam Saham #30195
TaiwanJ Pharmaceuticals Co., Ltd. operates as a specialized biotech firm... TaiwanJ Pharmaceuticals Co., Ltd. operates as a specialized biotech firm dedicated to the research, development, and commercialization of small molecule therapeutics. Initially, its focus within Taiwan has been on tackling chronic organ inflammation stemming from metabolic, autoimmune, or infectious causes. The company's growing pipeline also features specific compounds like JKB-122 and JKB-121, alongside a collection of innovative chemical entities. These new drugs are being developed to address persistent liver conditions and allergic respiratory ailments, such as asthma. TaiwanJ's comprehensive product portfolio is engineered to combat a wide array of diseases, encompassing hepatic inflammation and fibrosis, non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), various autoimmune disorders, asthma, and atopic dermatitis (eczema). Established in 2011, the company's operations are headquartered in Zhubei, Taiwan.
Harga Saham
$0.22227521
Kapitalisasi Pasar
$17.81M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-14.81%
Negara
TW
Perdagangan TaiwanJ Pharmaceuticals Co., Ltd. (6549)

Kategori

Riwayat harga saham TaiwanJ Pharmaceuticals Co., Ltd. (6549)
Harga penutupan tertinggi: $0.22 pada 2026-08-01

Harga penutupan terendah: $1.48 pada 2015-10-01
Riwayat harga saham TaiwanJ Pharmaceuticals Co., Ltd. dari 2015 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) -0.02%
2025 -4.42%
2024 -46.55%
2023 39.35%
2022 -2.83%
2021 -22.13%
2020 32.12%
2019 63.58%
2018 -45.16%
2017 -41.89%
2016 -53.24%
2015 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$527.89 35.09%
US
$996.61 51.72%
NL
$116.20 -20.17%
AU
$735.86 6.07%
CH
$257.75 14.92%
BE